what is better for weight loss tirzepatide or semaglutide vs Balanced Bodies | Semaglutide vs.

Foundayo (Orforglipron): Offering flexibility and significant weight loss results, Foundayo is an oral GLP-1 receptor agonist taken daily without food timing restrictions

And we saw there were cases where evidence had flip flopped based on larger and better studies that have come out

Originally discovered by Chugai as OWL833 and later licensed by Eli Lilly as LY3502970, orforglipron is an oral, non-peptide GLP-1 receptor partial agonist and was also selected for the FDAs National Priority Review Voucher pilot program

It is not FDA-approved for weight loss: its clinical development was halted after Phase 2b, so any use is off-label and should be supervised by a licensed provider